1Skalickd H Jr, Hordk J,Asehermann M, et al. Myocardial infarction, left ventricle remodeling and cellular therapy[J].Vnitr Let,2009,55(1) :37-44.
2Tendera M, Wojakowski W. Intraeoronary infusion of bone marrow--derived selected CD34+ CXCR4+ cells and non- selected mononuelear cells in patients with acute STEMI and reduced left ventrieular ejection fraction: results of randomized, multicetre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial[J]. Eur Heart J, 2009, 30 (11):1313-1221.
3Hagikura K, Fukuda N, Yokoyama SI. Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene[J]. Int J Cardiol,2010,142(1) :56-64.
8smith RC, Gardiner JC, Lyses JS, et al. Exploration of DSM-VI criteria in primary care patients with medically unexplained symptoms: Psychoso .m Med. 2005i67,(1): 123-129.
9Mayou R, Kirrnayer LJ, Simon G, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry. 2005;162(5):847-855.
10Fink P, Hansen MS, Oxbhoj ML. The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res. 2004;56(4): 413-418.
